A multiethnic clinical study found that the intake of flavonoids reduces the risk of NAFLD and assists in normalizing NAFLD status by attenuating the fatty liver index, serum aspartate aminotransferase, and alanine aminotransferase (Mazidi et al., 2019). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.